Pomegranate polyphenols in beverages, but not in supplements, help lower the postprandial glycaemic response of bread, suggests a study. Additionally, microbial metabolites from pomegranate polyphenols may further modulate sugar metabolism much later in the postprandial period.
Skipping breakfast may contribute to better insulin signalling, according to a recent study, which shows that expression of the IRS2 gene, involved in insulin signalling, is upregulated in both lean and obese individuals following a 6-week morning fasting programme.
The use of masculinizing hormone therapy in female-to-male (FTM) transgenders is not likely to lead to significant changes in bone mineral density (BMD), but in male-to-female (MTF) individuals, the use of feminizing hormone therapy may result in an increase in BMD at the lumbar spine, a recent study has found.
Young onset type 2 diabetes (YOD) patients appear to be more responsive to metformin, requiring significantly lower insulin with metformin add-on doses than late onset type 2 diabetes (LOD) patients to achieve glycaemic control, a recent study has revealed.
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
New drug applications approved by US FDA as of 15-30 Aug which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.